Volume 85, Issue 4, Pages (April 2014)

Slides:



Advertisements
Similar presentations
Susan R. Mendley, Nancy L. Majkowski, Dale A. Schoeller 
Advertisements

A Clinical Approach to the Treatment of Chronic Hypernatremia
Volume 59, Issue 3, Pages (March 2001)
A powerful new agonist: flooding the system with growth hormone
Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward  Adeera Levin, Paul E. Stevens  Kidney International 
Anemia management in chronic kidney disease
Volume 61, Issue 6, Pages (June 2002)
Red blood cell life span and ‘erythropoietin resistance’
C-reactive protein and dialysis access
Alex Castellarnau, Michael Werner, Roman Günthner, Marten Jakob 
Determinants of phosphorus mobilization during hemodialysis
Pharmacokinetics and pharmacodynamics of oral tolvaptan in patients with varying degrees of renal function  Susan E. Shoaf, Patricia Bricmont, Suresh.
Reassessment of the care of the patient with chronic kidney disease
Volume 70, Issue 10, Pages (November 2006)
C-reactive protein and dialysis access
Volume 81, Issue 4, Pages (February 2012)
Jeffrey C. Fink, Glenn M. Chertow  Kidney International 
Volume 82, Issue 1, Pages (July 2012)
George A. Kaysen, Burl R. Don
Prediction of hypertension in chronic hemodialysis patients
How to interpret the eGFR in patients with small body surface area
The KDIGO guideline for dialysate calcium will result in an increased incidence of calcium accumulation in hemodialysis patients  Frank A. Gotch, Peter.
Volume 67, Issue 1, Pages (January 2005)
Volume 53, Issue 4, Pages (April 1998)
Volume 74, Issue 3, Pages (August 2008)
The importance of increased dialysis and anemia management for infant survival in pregnant women on hemodialysis  Sai Subhodhini Reddy, Jean L. Holley 
Volume 74, Issue 3, Pages (August 2008)
Volume 84, Issue 1, Pages (July 2013)
Total body water reference values and prediction equations for adults
Susan R. Mendley, Nancy L. Majkowski, Dale A. Schoeller 
Nephrology Crosswords: Hemodialysis
Gentamicin pharmacokinetics during slow daily home hemodialysis
The analysis of survival data: the Kaplan–Meier method
Volume 84, Issue 5, Pages (November 2013)
Estimation of Adipose Pools in Hemodialysis Patients From Anthropometric Measures  George A. Kaysen, Peter Kotanko, Fansan Zhu, Shubho R. Sarkar, Steven.
Volume 69, Issue 10, Pages (May 2006)
The role of bioimpedance and biomarkers in helping to aid clinical decision-making of volume assessments in dialysis patients  Simon J. Davies, Andrew.
Volume 73, Issue 12, Pages (June 2008)
Volume 76, Issue 6, Pages (September 2009)
Volume 72, Issue 12, Pages (December 2007)
Effects of hemodialysis on cardiac function
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Alternate-day dialysis may be needed for hemodialysis patients
Volume 85, Issue 1, Pages 3-4 (January 2014)
Volume 61, Issue 1, Pages (January 2002)
Volume 55, Issue 4, Pages (April 1999)
Nephrology Crossword: Glomerulonephritis
Volume 80, Issue 3, Pages (August 2011)
Current status of maintenance hemodialysis in Beijing, China
Volume 76, Issue 6, Pages (September 2009)
Volume 58, Issue 1, Pages (July 2000)
Volume 83, Issue 4, Pages (April 2013)
Volume 80, Issue 10, Pages (November 2011)
Volume 65, Issue 4, Pages (April 2004)
Volume 60, Issue 6, Pages (December 2001)
The hypothesis that abnormal BH4 metabolism impairs kidney function
Assessing the impact of different imputation methods on serial measures of renal function: The Strong Heart Study  N.-M. Shara, J.-G. Umans, W. Wang,
ANCA comes of age—but with caveats
The arrow of bioimpedance
Volume 75, Issue 7, Pages (April 2009)
Volume 62, Issue 5, (November 2002)
Volume 81, Issue 8, Pages (April 2012)
Volume 59, Issue 3, Pages (March 2001)
Strategies for iron supplementation: Oral versus intravenous
Antioxidant therapy in hemodialysis patients: a systematic review
Volume 69, Issue 3, Pages (February 2006)
Where vaptans do and do not fit in the treatment of hyponatremia
Estimation of lean body mass in children
Volume 83, Issue 3, Pages (March 2013)
Presentation transcript:

Volume 85, Issue 4, Pages 898-908 (April 2014) Comparison of fluid volume estimates in chronic hemodialysis patients by bioimpedance, direct isotopic, and dilution methods  Jochen G. Raimann, Fansan Zhu, Jack Wang, Stephan Thijssen, Martin K. Kuhlmann, Peter Kotanko, Nathan W. Levin, George A. Kaysen  Kidney International  Volume 85, Issue 4, Pages 898-908 (April 2014) DOI: 10.1038/ki.2013.358 Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 1 Linear regression plot: total-body water (TBW) (single-frequency (SF) and multi-frequency (MF) and (bromide (Br)+total-body potassium (TBK)) vs. deuterium oxide (D2O)). Linear regression of TBW as estimated by a direct ‘gold-standard approach’ with D2O dilution (TBW D2O) versus TBW as assessed by whole-body MF and SF bioimpedance analysis, and an indirect ‘gold-standard approach’ using the sum of intracellular fluid volume (as assessed per TBK (ICF TBK)) and extracellular fluid volume ((as per bromide dilution (ECF Br)). Solid symbols (▴, ●, and ▪, respectively) indicate those excluded from the sensitivity analysis. Kidney International 2014 85, 898-908DOI: (10.1038/ki.2013.358) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 2 Bland–Altman plot (N=49). Bland–Altman plot showing the difference between total-body water (TBW) as estimated by a direct ‘gold-standard approach’ with deuterium dioxide dilution (TBW D2O) and TBW as assessed by whole-body (a) single-frequency and (b) multi-frequency bioimpedance analysis, and (c) an indirect ‘gold-standard approach’ using the sum of intracellular fluid volume (as assessed per total-body potassium (ICF TBK)) and extracellular fluid volume ((as per bromide dilution (ECF Br)). (a) TBW (D2O vs. SF-BIA); (b) TBW (D2O vs. MF-BIS); (c) TBW (D2O vs. (Br+TBK)). Mean±2 s.d. is indicated; men are denoted by filled (▴, ●, and ▪, respectively) and women by unfilled symbols (Δ, ○ and □, respectively). Kidney International 2014 85, 898-908DOI: (10.1038/ki.2013.358) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 3 Linear regression plot: intracellular fluid (ICF) (single-frequency (SF) and multi-frequency (MF) and (deuterium dioxide (D2O)-bromide (Br)) vs. total-body potassium (TBK)) (N=49). Linear regression of ICF volume as estimated by a direct ‘gold-standard approach’ with TBK (ICF TBK) vs. ICF as assessed by whole-body MF and SF bioimpedance analysis and an indirect ‘gold-standard approach’ using the difference between total-body fluid volume (assessed with D2O dilution (TBW D2O)) and extracellular fluid volume (as per bromide dilution (ECF Br)). Solid symbols (▴, ●, and ▪, respectively) indicate those excluded for the sensitivity analysis. Kidney International 2014 85, 898-908DOI: (10.1038/ki.2013.358) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 4 Bland–Altman plot (N=49). Bland–Altman plot showing the difference between intracellular fluid as estimated by a direct ‘gold-standard approach’ with total-body potassium (ICF TBK) and ICF as assessed by whole-body (a) single-frequency and (b) multi-frequency bioimpedance analysis, and (c) an indirect ‘gold-standard approach’ using the difference between total-body fluid volume (assessed with deuterium dioxide dilution (TBW D2O)) and extracellular fluid volume (as per bromide dilution (ECF Br)). (a) ICF (TBK vs. SF-BIA); (b) ICF (TBK vs. MF-BIS); (c) ICF (TBK vs. (D2O-Br)). Mean±2s.d. is indicated; men are indicated by filled (▴, ●, and ▪, respectively) and women by unfilled symbols (Δ, ○, and □, respectively). Kidney International 2014 85, 898-908DOI: (10.1038/ki.2013.358) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 5 Linear regression plot: extracellular fluid (ECF) (single-frequency (SF) and multi-frequency (MF) (deuterium dioxide (D2O)-total-body potassium (TBK)) vs. bromide (Br)) (N=49). Linear regression of ECF as estimated by a direct ‘gold-standard approach’ with Br dilution (ECF Br) vs. ECF as assessed by whole-body MF and SF bioimpedance analysis, and an indirect ‘gold-standard approach’ using the difference between total-body fluid volume (assessed with deuterium dioxide dilution (TBW D2O)) and intracellular fluid volume (as measured using total-body potassium (ICF TBK)). Solid symbols (▴, ●, and ▪, respectively) indicate those excluded from the sensitivity analysis. Kidney International 2014 85, 898-908DOI: (10.1038/ki.2013.358) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 6 Bland–Altman plot (N=49). Bland–Altman plot showing the difference between of intracellular fluid volume as estimated by a direct ‘gold-standard approach’ with bromide dilution (ECF Br) and ECF as assessed by whole-body (a) single-frequency and (b) multi-frequency bioimpedance analysis, and (c) an indirect ‘gold-standard approach’ using the difference between total-body fluid (assessed with deuterium dioxide dilution (TBW D2O)) and intracellular fluid volume (as per total-body potassium (ICF TBK)). (a) ECF (Br vs. SF-BIA); (b) ECF (Br vs. MF-BIS); (c) ECF (Br vs. (D2O-BK)). Mean±2s.d. is indicated; men are indicated by filled (▴, ●, and ▪, respectively) and women by unfilled symbols (Δ, ○, and □, respectively). Kidney International 2014 85, 898-908DOI: (10.1038/ki.2013.358) Copyright © 2014 International Society of Nephrology Terms and Conditions

Figure 7 Bland–Altman plot: extracellular fluid (ECF) (bromide (Br) vs. (deuterium dioxide (D2O)-total-body potassium (TBK)) (N=49). Modified Bland–Altman plot (only using the indirect estimation method on the x-axis) showing the comparison between ECF volume (ECF) as per Br dilution (ECF Br) and ECF as per the indirect estimation method (ECF=TBW D2O-ICF TBK). Mean±2s.d. is indicated. Kidney International 2014 85, 898-908DOI: (10.1038/ki.2013.358) Copyright © 2014 International Society of Nephrology Terms and Conditions